On 1-2 December 2022, the European Audit Committee Leadership Network (EACLN) met in London to discuss proposed sustainability standards with the International Sustainability Standards Board (ISSB); globalization trends and how companies are…
In recent years, businesses have been faced with an array of novel crises. Today’s environment of 24/7 connectedness, combined with a societal breakdown in trust, puts pressure on companies to respond quickly and transparently to unprecedented…
Boards and General Management
As business, regulatory, and risk environments evolve and become increasingly complex, internal audit (IA) must also evolve. In addition to providing objective assurance, internal audit teams are increasingly playing a consultative role within large…
Investors, regulators, and the broader public are all calling for large public companies to comprehensively address diversity, equity, and inclusion (DEI). Boards have increased their engagement with DEI issues since the summer of 2020, but…
Board and committee effectiveness, Boards and General Management
On November 10-11, 2022, the Audit Committee Leadership Network (ACLN) met in Washington, DC to discuss:
Top challenges for audit committees, a members-only discussion
SEC update and enforcement discussion with Elad Roisman, partner at…
Board and committee effectiveness, Boards and General Management, Board risk oversight, Corporate and board regulatory matters, Investor perspectives on public companies
Approaching the end of 2022, compensation committees face continued scrutiny of executive compensation levels and how pay connects to company performance, while also confronting an economic climate of inflation, market volatility, and impending…
Board and committee effectiveness, Boards and General Management, Executive Compensation
Boards are under pressure from all corners to demonstrate their value. One key to board performance is building a culture of continuous improvement. To do so, many boards are taking a regular, honest look at both the board’s overall performance and…
Boards and General Management
Biomarkers and next-generation sequencing (NGS) tests have become pivotal in the diagnosis and treatment of diseases. Recent data shows, for example, increasing use of biomarker testing by oncologists. NGS testing is not only increasingly prevalent…
Precision medicine and diagnostics / Healthcare
As boards confront unprecedented levels of uncertainty and an increasingly complex risk landscape, audit committees are faced with ever-growing responsibilities. In a members-only session of the European Audit Committee Leadership Network (EACLN)…
Fraud is a risk to any organization, and its damage can reach beyond those involved to impair trust in capital markets more broadly. Recent high-profile frauds in Europe have led governance stakeholders to ask what more can be done to strengthen…